We are live on ! Find out more
PAVM icon

PAVmed
PAVM

7 hedge funds and large institutions have $582K invested in PAVmed in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

40% more funds holding

Funds holding: 5 → 7 (+2)

3% more capital inflows, than outflows

Capital inflows: $323K | Capital outflows: $313K

0.09% more ownership

Funds ownership: 0.71% → 0.8% (+0.09%)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$184K
2
Goldman Sachs
Goldman Sachs
New York
+$124K
3
Deutsche Bank
Deutsche Bank
Germany
+$8.28K
4
BlackRock
BlackRock
New York
+$4.14K
5
Moloney Securities Asset Management
Moloney Securities Asset Management
Missouri
+$2.07K

Top Sellers

Rank Fund Capital Flow
1
Fusion Family Wealth
Fusion Family Wealth
New York
-$251K
2
Levin Capital Strategies
Levin Capital Strategies
New York
-$62.1K

PAVM Hedge Fund Activity: Q3 2017 in Review

7 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2017, worth a combined $582K — up 21% from $481K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PAVM positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $184K. The largest seller was Fusion Family Wealth, exiting entirely with an estimated $251K sold.

  • 7 institutional investors held PAVmed (PAVM) as of Q3 2017, up from 5 in Q2 2017.
  • Funds reported $582K of PAVmed stock for Q3 2017, up 21% quarter-over-quarter.
  • 3 funds opened new PAVmed positions in Q3 2017 and 1 closed out, a net change of +2 holders.
  • The largest PAVmed buyer in Q3 2017 was Millennium Management, an estimated $184K added.
  • The largest PAVmed seller in Q3 2017 was Fusion Family Wealth, an estimated $251K sold.

Based on aggregated 13F filings for Q3 2017.